Abdurrahman, A., M. A. S. Rijal, H. Yusuf, Norhayati, and G. Rizaldi. “In Silico Study of Naringin As an Anti-HER-2 Receptor in the Treatment of Breast Cancer”. Borneo Journal of Pharmascientech, Vol. 8, no. 2, Oct. 2024, pp. 137-48, doi:10.51817/bjp.v8i2.535.